There are 859 resources available
LBA8 - Preliminary efficacy of pembrolizumab plus lenvatinib (PL) in recurrent clear cell gynecological cancer (CCGC): Phase II LARA trial (GCGS-OV4/ APGOT-OV3)
Presenter: Natalie Ngoi
Session: Mixed Proffered paper and Mini oral session: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
291MO - Determining the maximum tolerated dose of paclitaxel combined with fixed dose of cisplatin for hyperthermic intraperitoneal chemotherapy in ovarian cancer: A multicenter phase I trial
Presenter: Jing Li
Session: Mixed Proffered paper and Mini oral session: Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Invited Discussant 74MO, 75MO, 76MO and 77MO
Presenter: Irene Braña
Session: Mixed Proffered paper and Mini oral session: Developmental and precision medicine
Resources:
Slides
Webcast
Invited Discussant LBA8 and 291MO
Presenter: Keiichi Fujiwara
Session: Mixed Proffered paper and Mini oral session: Gynaecological cancers
Resources:
Slides
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mixed Proffered paper and Mini oral session: Developmental and precision medicine
Resources:
Webcast
Q&A and discussion
Presenter: All Speakers
Session: Mixed Proffered paper and Mini oral session: Gynaecological cancers
Resources:
Webcast
Welcome address by the ESMO President, Prof. Andrés Cervantes
Presenter: Andres Cervantes
Session: Opening session and Keynote lecture
Resources:
Slides
Webcast
Scientific Co-Chairs: Programme and key highlights of the meeting
Presenter: Sanjay Popat
Session: Opening session and Keynote lecture
Resources:
Webcast
Token of Appreciation Endorsing society representatives
Presenter: All Speakers
Session: Opening session and Keynote lecture
Resources:
Webcast